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Abstract. To study the intranuclear localization of the 
Ul-specific snRNP C  protein and its assembly into U1 
snRNPs, we injected transcripts encoding a myc- 
tagged C  protein into amphibian oocytes. The distribu- 
tion of protein translated from the injected RNA was 
essentially the same in continuous and pulse-label ex- 
periments. In both cases the C  protein localized within 
the germinal vesicle in those structures known to con- 
tain U1  snRNPs,  namely the lampbrush chromosome 
loops and hundreds of extrachromosomal granules 
called snurposomes.  Oocytes were also injected with 
an antisense oligodeoxynucleotide that caused trunca- 
tion of U1  snRNA at the 5' end. In these oocytes, 
myc-tagged C  protein localized normally in the germi- 
nal vesicle and could be immunoprecipitated together 
with truncated U1  snRNA.  These experiments suggest 
that the C  protein can enter the germinal vesicle on its 
own and there associate with previously assembled U1 
snRNPs.  In transfected tissue culture cells, the myc- 
tagged C  protein localized within the nucleus in a 
speckled pattern similar to that of endogenous U1 
snRNPs. 
T 
HE small nuclear ribonucleoproteins (snRNPs) ~ U1, 
U2, U4/U6, and U5 are required for pre-mRNA splic- 
ing (Steitz et al., 1988), along with other non-snRNP 
factors (Ruskin et al., 1988; Fu and Maniatis, 1990; KrOner 
and Utans, 1991). When an RNA that contains an intron is 
added to a suitable nuclear extract, these components assem- 
ble on the RNA to form an active splicing complex called 
a spliceosome (Brody and Abelson, 1985; Grabowski et al., 
1985;  Frendeway and  Keller,  1985;  Maniatis  and  Reed, 
1987).  Although the biochemical requirements and kinetics 
of spliceosome formation have been studied in detail in vitro, 
relatively little is known about the site of splicing within the 
nucleus. Immunofluorescent staining and in situ hybridiza- 
tion show that splicing components are not uniformly dis- 
tributed in somatic cell nuclei (Lerner et al., 1981; Spector, 
1984; Nyman et al., 1986; Carmo-Fonseca et al., 1991a,b; 
Carter et al., 1991; Spector et al., 1991), suggesting that ei- 
ther splicing itself or the assembly of splicing components 
takes place at specific intranuclear sites.  In giant chromo- 
somes, splicing components occur in the actively transcrib- 
ing regions, namely the puffs and Balbiani rings of dipteran 
polytene chromosomes (Sass and Pederson, 1984; Vazquez- 
Nin et al., 1990) and the loops of lampbrush chromosomes 
from amphibian oocytes (Gall and Callan, 1989; Wu et al., 
1991; Tsvetkov et al.,  1992).  Furthermore, Beyer and col- 
leagues have shown by EM that transcripts from Drosophila 
genes almost certainly undergo splicing before they leave the 
sites of synthesis on the chromosomal DNA (Osheim et al., 
1985;  Beyer and Osheim,  1988).  Thus, transcription and 
1. Abbreviations used in thispaper: GV, germinal vesicle; snRNP, small nu- 
clear ribonucleoprotein. 
splicing probably occur simultaneously under many condi- 
tions in the nucleus, even though the two processes are not 
obligately linked (Pan and Prives,  1988;  Tsvetkov et al., 
1992). 
In the amphibian germinal vesicle (GV),  splicing compo- 
nents are also found in hundreds to thousands of extrachro- 
mosomal granules called snurposomes  (Gall  and Callan, 
1989; Wu et al.,  1991). Three types, designated A, B, and 
C  snurposomes, can be distinguished on the basis of mor- 
phology and molecular composition. A and B snurposomes 
are ~1--4 #m in diameter, whereas Cs vary from as small as 
1/zm to giant structures 20/~m in diameter. The A snurpo- 
somes contain only U1 snRNA and associated proteins; so 
far, they have been identified in GVs of the newt Notoph- 
thalmus, but not in Xenopus. B snurposomes are generally 
the most abundant. They are known to contain the five splic- 
ing snRNAs, several  snRNP proteins, at least one essential 
non-snRNP splicing factor (SC35),  and hnRNP proteins. 
The composition of the C's is problematic. They stain more 
or less uniformly with antibodies directed against the Sm 
proteins and against the trimethylguanosine cap found on 
most snRNAs. Nevertheless, in situ hybridization of splicing 
snRNAs is limited to small internal inclusions (our own un- 
published observations). 
The functions of snurposomes are still obscure. Because 
B  snurposomes and the actively transcribing loops of the 
lampbrnsh chromosomes share such a  variety of splicing 
components, these two structures may be related in some 
way. Among the (nonexclusive) possibilities are that B snur- 
posomes serve as sites for (a) preassembly of spliceosome 
components destined for the loops, (b)  storage of snRNPs 
used later in embryogenesis. (c) recycling of splicing compo- 
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itself. 
One approach to understanding the relationships  among 
the  various  snRNP-contalning structures  in  the  GV is  to fol- 
low the  incorporation  of  newly synthesized  splicing  compo- 
nents  into  these  structures  by microscopic techniques.  If, at 
the same time,  the  assembly of  snRNPs or  larger  complexes 
is  followed  biochemicaUy, some idea  about sites  of  assembly 
can be gained. To this  end we have studied  the U1-specific 
snRNP C protein  in  the  GV. We synthcs~ myc-tagged tran- 
scripts from a cDNA  clone of the C protein and injected 
these  into  newt and Xenopus oocytes.  We then followed the 
incorporation of the newly synthesized  C protein  into  vari- 
ous nuclear structures by immunofluorcscence.  Wc  also 
demonstrated  that  new C  protein can associate with pre- 
existing  U1 snRNPs within  the  nucleus.  For  comparison, wc 
examined the localization  of  newly synthesized  C protein  in 
somatic cells  after  transfection  with the cDNA  clone. 
Materials and Methods 
Isolation of the snRNP C cDNA 
The snRNP C cDNA was isolated from a lambda ZAP expression  library 
made from Xenopus laevis ovary mRNA (Tafuri and Wolffe, 1990).  The 
snRNP C coding region  was one of two open reackng  frames in a clone 
selected  for  its  ability  to  bind RNA. After  conversion  of  the  lambda phage 
to the corresponding Bluescript SK(-) phngemid, designated p12, the entire 
insert was sequenced by the dideoxy chain termination method (Sanger et 
al.,  1977).  The identity  of  the  snRNP C coding region  was determined by 
a sequence homology search  in  the  GenBank data  base.  The sequence data 
arc available  from EMBL/GenBank/DDBJ  under accession  No. X63892. 
Construction of myc-tagged snRNP C Fusion Protein 
To produce clone pCMA, the 6 myc tags of Bhiescript KS( +)MT7 (Roth 
et al.,  1991) were fused to the carboxy terminus of the snRNP C eDNA, 
along with the 3' untranslated region of NO38 (Peculis  and Gall, 1992). 
Positive clones were identified by restriction digests and sequencing. One 
positive clone was used for all further studies;  it was called pCMA for C 
protein-Myc-poly  A. pCMA bad a unique open reading  frame, starting at 
the AUG codon of the snRNP C fragment, continuing through the 6 myc 
tags, and ending 15 amino acids further downstream at the beginning of the 
NO38 3' untranslated region (see Fig. 2). 
In Vitro Transcription 
Plasmid pCMA was linearized at a unique BamHI site downstream of the 
poly A tail. Capped in vitro transcripts were produced from the T7 pro- 
motet according to previously described methods (Roth and Gall, 1989). 
After phenol extraction and ethanol precipitation, an aliquot of the RNA 
was checked for size and quality by etectrophoresis on a 2 % ngarose gel 
containing 1.5% formaldehyde.  The remaining RNA was resuspended at 1 
mg/ml and  used for  oocyte  injections.  Radiolabeled  antisense  transcripts  of 
various U snRNAs  were made as described by Hamm et al. (1989). 
Oocyte Injections 
Injections of oligos Ula and U2b, complementary to regions of UI and U2 
snRNAs ~vely,  were made as described by Pan and Prives (1988), 
except that injections were made into the cytoplasm instead of the nucleus 
(Tsvetkov et al., 1992). Oocyte injections and analysis of translation prod- 
ucts by immunoblotting were made according to Peculis and Gall (1992). 
For double injections with antisense oligos and pCMA, oocytes  were in- 
jected with the oligos 4-12 h before injection  with pCMA. For immunoflno- 
rescence analysis of pCMA translation products, preparations of spread GV 
contents were made as described by Wu et al. (1991). 
lmmunoprecipitation 
Injected and control oocytes were held overnight in OR-2 saline (Wallace 
et al.,  1973).  For each precipitation 10-30 GVs were isolated by hand in 
GV isolation buffer (83 mM KCI,  17 mM NaC1, 6.5 mM Na2HPO4, 3.5 
mS KI-I2PO4, 1 mM MgC12 and 1 mM DTT, pH Z2), washed free of yolk, 
and transferred to an Eppendorf tube on ice.  After addition of 500/~1 of 
NET-2 (150 mM NaC1, 50 mM Tris, pH 7.4, 0.05% NP-40),  the GVs were 
homogenized  by sonication.  The extract was precleared by centrifugation 
for 10 rain at 4~  and the supernate was used for immunoprecipitations  with 
mAb 3(12 (Lerner et al.,  1981) or mAb 9E10 (Evan et al., 1985) bound to 
Protein A-Sepbarose CL-4B beads (Pbarmacia Fine Chemicals,  Piscata- 
way, NJ), following the technique described by Steitz (1989). mAB 3(12 was 
coupled directly to the beads, but the low affinity of mAb 9El0 for protein 
A required that it be coupled by a secondary rabbit anti-mouse antibody. 
For analysis of immunoprecipitnted  proteins, the beads were boiled in SDS 
sample buffer, the extracted  proteins fractionated on 7-17% gradient gels 
(Laananli, 1970) and analyzed by immunoblotting (Burnette,  1981). For 
analysis by Northern blotting,  the RNAs were extracted  from the precipi- 
tated complexes  following the protocol of Steitz  (1989). 
RNA Isolation 
Single GVs were collected in GV isolation buffer, transferred to t00 ~l TE 
(10 mM "Iris, pH 8.0, 1 mM EDTA),  1% SDS, and sonicated.  The solution 
was extracted twice with phenol, and twice with phenol-chloroform (1:1 
vol/vol). It was then brought to 300 mM Na acetate, 5/~g of glycogen was 
added as carrier, and RNAs  were precipitated by addition of 2  vols  of 
ethanol. 
Northern Blots 
RNA from individual GVs or from immunoprecipitations was separated on 
10% denaturing acrylamide gels, and transferred to GeneScreen membrane 
(Dupont Co., Boston, MA) by electroblotting  (0.3 amp, overnight) in lx 
TAE (40 mM Tris-acetate,  2 mM EDTA, pH 7.4). The RNA was immobi- 
lized by UV crosslinking (1.9 mJoule/cm  2) and hybridized at 65~  for 12 h 
with 32p-labeled antisense probes in high SDS buffer (Church and Gilbert, 
1984). Membranes were washed once for 15 rain in 1￿  SSC (0.15 M NaC1, 
0.015 M Na citrate, pH 7.0), 0.5% SDS, followed by two 15-rain washes in 
0.2￿  SSC, 0.5%  SDS at 65~  and exposed while moist to x-ray film for 
1-12 h at room temperature. 
Tissue Culture Transfection 
For transfection of the myc-snRNP C fusion construct into tissue culture 
cells, the coding region of pCMA and the poly A tail of NO38 were cloned 
into pCMX (Umesono et al., 1991). HeLa cells were grown in MEM sup- 
plemented with 10% FCS. One day before transfection, 5  x  105 cells were 
placed in 10-cm petri dishes containing acid-etched  coverslips.  Transfec- 
tions were made by the calcium phosphate precipitation method (Ausubel 
et al., 1987). DNA precipitates were left on the cells overnight, which were 
then washed in PBS, covered with fresh medium, and allowed to recover 
for 24 h. 
Cells on coverslips  were fixed and permeabilized according to Fu and 
Maniatis (1990) except that methanol replaced acetone in the permeabiliza- 
tion step. 
After fixation, cells were washed in 70% ethanol, and transferred  to PBS. 
Immunofluorescent  staining was  performed as  described  by ~  et  al. 
(1991). 
Microscopy 
Microscopes and filter combinations used for phase contrast, DIC (Nomar- 
ski), fluorescence,  and confocal laser scan microscopy are described in Wu 
et al. (1991). 
Antibodies 
mAb 9El0 recognizes a 10-amino acid peptide in the human c-myc protein 
(Evan et al., 1985). mAb Y12 recognizes the Sm epitope found on several 
snRNP proteins (Lerner et al., 1981). Human serum 361 is known to immu- 
noprecipitate U1 snRNPs (D. Wassarman,  unpublished observation). 
Results 
Isolation and Characterization of  a Xenopus cDNA 
Encoding the U1 snRNP C Protein 
We have isolated a Xenopus laevis eDNA clone that encodes 
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gion was  found as  one of two open reading  frames in a 
lambda ZAP clone derived from a "baby ovary" eDNA li- 
brary (Tafuri and Wolffe, 1990). Sequencing of the entire in- 
sert and a subsequent search in the GenBank DNA data base 
showed that one of the two open reading frames coded for 
the Xenopus homologue of the human snRNP C protein. The 
480-bp coding region showed 80%  identity to the human 
eDNA (Sillekens et al.,  1988) with a corresponding 92% 
identity on the protein level (Fig.  1). 
Like its human counterpart, the Xenopus C protein con- 
tains a putative zinc finger cys-cys/his-his motif (Berg, 1988) 
near the amino terminus.  The zinc finger is necessary for 
binding of the C protein to the U1 snRNP (Nelissen et al., 
1991). Consistent with this finding, there are no amino acid 
differences between the Xenopus and human proteins in the 
zinc finger region (Fig.  1). 
Construction of myc-snRNP C Fusions 
To study the intranuclear transport and localization of the C 
protein we wanted to inject in vitro synthesized transcripts 
encoding the C protein into newt and Xenopus oocytes and 
follow the translation products by immunofluorescence and 
immunoblotting. To distinguish newly synthesized from en- 
dogenous C protein we tagged the C protein with a 10-amino 
acid  sequence derived from the human  c-myc gene.  The 
resulting fusion protein could then be detected with mAb 
9El0 specific for the myc tag (Evan et al.,  1985). 
Four in-frame constructs were made that contained the C 
protein cDNA fused to an oligonucleotide encoding either 
a single myc tag or six tandem tags. Two constructs had the 
tags at the amino terminus, two at the carboxy terminus. To 
increase the stability of the RNAs after injection into oo- 
cytes, the 3' end of our constructs consisted of the 3' untrans- 
lated region and poly A  tail of the Xenopus NO38 cDNA 
(Peculis and Gall, 1992). In vitro transcripts of all constructs 
were made, the RNAs were translated either in vitro, or in 
vivo after injection into oocytes, and the resulting fusion 
proteins were detected by immunoblots and by immunofluo- 
rescence of cytological preparations.  In  oocytes the  two 
amino-terminal  myc  fusions  accumulated  in  the  GV,  as 
shown by immunoblots of GV proteins, but neither could be 
detected on the chromosomes or other cytological structures 
in spread preparations of GV contents (data not shown). Pre- 
sumably, therefore, the proteins were in the soluble phase of 
the GV. Both carboxy-terminal fusions showed strong signals 
on immunoblots of GV proteins and on immunofluorescently 
stained cytological preparations. The construct with a single 
myc tag had a calculated molecular mass of 18.9 kD, that 
with  six tags  a  mass  of 29 kD.  On  gels,  both constructs 
showed slightly larger apparent molecular masses of 24 and 
33 kD, respectively. A  similar discrepancy between calcu- 
lated and apparent molecular weight has also been observed 
for the human snRNP C protein and is believed to be caused 
by posttranslational modifications of  the protein (Sillekens et 
al.,  1988).  For all  subsequent  studies  we used construct 
pCMA, which has six tags at the carboxy terminus (Fig. 2). 
Intranuclear Localization of  snRNP C Fusion Protein 
Capped  in  vitro transcripts  of pCMA  were injected into 
Notophthalmus oocytes. The translation products were fol- 
lowed at various times after injection by immunofluores- 
1  CAG GGA GAC GAA CGC GCC ATT ACC AAC ATG CCG AAG TTT TAC TGT  45 
M  P  K  F  Y  C  6 
46  GAC TAC TGC GAT ACG TAT CTC ACC CAT GAT TCT CCT TCA GTC CGT  90 
7  D  Y  C  D  T  Y  L  T  H  D  S  P  S  V  R  22 
91  AAG ACT CAT TGT AGT GGA AGA AAG CAC AAG GAG AAT GTG AAA GAT  135 
22  K  T  R  C  S  G  R  K  R  K  E  N  V  K  D  36 
136  TAT TAT CAG AAG TGG ATG GAA GAG CAG GCA CAG AGC CTA ATT GAC  180 
37  Y  Y  Q  K  W  M  E  E  Q  A  Q  S  L  I  D  51 
181  AAA ACC ACC GCC GCA TTT CAA CAA GGA AAA ATA CCA CCA ACA OCT  225 
52  K  T  T  A  A  F  Q  Q  G  K  I  P  P  T  P  66 
226  TTT GCA GCT CCG CCA GCT GGA ~T  GCT ATG ATC CCA CCA OCT CCA  270 
67  F  ~  A  P  P  ~  ~  S  A  H  I  P  P  P  P  81 
271  AGC TTG GGT GGA CCT CCT CGA OCT GGA ATG ATG CCT GCT CCC CCC  315 
82  S  L  ~  G  P  P  R  P  G  M  M  P  A  P  ~  96 
316  ATG GCT GGC OCT OCT ATG ATG OCA ATG ATG GGA CCA CCT OCT (=CA  360 
97  M  A  G  P  P  M  M  P  M  M  G  P  P  P  P  III 
361  GGA AT(;  ATG CCA GTA GGC CAT GGT CCT GGT ATG AGA CCA CCC ATG  405 
112  G  M  M  P  V  G  B  Z  P  G  M  R  P  P  M  126 
406  GGA GCT CAC ATG OCT ATG ATG CCT GGT CCA CCC ATG ATG CGT CCA  450 
127  G  ~  H  M  P  M  M  P  G  P  P  M  M  R  P  141 
451  CCT ACA CGT OCT ATG ATG CTA CAG TCC CGA CCT GGC ATG GCA CGT  495 
142  P  2  R  P  M  M  .5  Q  Z  R  P  G  M  ~  R  156 
496  CCT C~%T  CGA TAA AAC TTT TT 515 
157  P  D  R  *  159 
Figure 1. Nucleotide sequence of the Xenopus U1 snRNP C gene 
and its conceptual amino acid translation. The amino-terminal por- 
tion of  the molecule is identical in the human and Xenopus proteins. 
Positions at which they differ, in the middle and carboxy-terminal 
regions, are underlined. A putative zinc finger cys-cys/his-his motif 
is shown in bold face. The C/aI restriction site, used to fuse the 
snRNP C encoding region to the myc tags, is also shown in bold 
face. These sequence data axe available from EMBL/GenBank/ 
DDBJ under accession number X63892. 
cence of spread nuclear preparations and by immunoblots of 
nuclear and cytoplasmic proteins.  Immunoblots showed a 
continuous nuclear accumulation of newly  synthesized C 
protein for up to 42 h (Fig. 3). Within the GV, the sites of 
highest  concentration  detectable  by  immunofluorescence 
changed with time (Fig. 4). At early time points, 4-10 h after 
injection, a weak but clearly recognizable labeling of C snur- 
posomes was observed, whereas other structures were not 
detectably labeled (Fig. 4, a and b). Labehng of C snurpo- 
somes  increased  in  intensity  until  '~48  h.  Beginning  at 
~14-18 h, loops and B snurposomes showed the first signs 
of label (Fig. 4, c and d), which gained in intensity during 
the next 24--48 h (Fig. 4, e and f), with maximum labeling 
of all mentioned structures roughly 60 h after injection (Fig. 
4, g and h). C snurposomes were usually the brightest struc- 
T• 
8al_~HI 
....  SNRNP  C  J  6  myc  I  N038  3'  UTR 
lqgure 2. Diagram of the insert in plasmid pCMA. Sequences en- 
coding 6 concatenated myc epitopes are fused to the 3' end of the 
snRNP C eDNA, followed by the 3' untranslated region of NO38 
(Peculis and Gall, 1992). The whole construct is inserted in Blue- 
script KS(-) downstream of the phage "17 promotor. Lineafization 
of  pCMA with BamHI allows in vitro synthesis of  runoff  transcripts 
from the "1"7  pmmotor. 
Jantsch and Gall Ul-specific  Small Nuclear Ribonucleoprotein  C Protein  1039 Figure 3. Nuclear accumulation of the snRNP C protein. Oocytes 
of the newt Notophthalmus were injected with transcripts from 
pCMA. At 0, 5, 18, 30, and 42 h after injection, proteins from six 
GVs and two enucleated oocytes (C) were electrophoresed, trans- 
ferred to a polyvinylidene  fluoride membrane (Immobilon-P; Mil- 
lipore Corp., Bedford, MA), and probed with mAb 9El0, which 
detects the myc sequences in the myc-snRNP  C fusion protein. Be- 
cause a GV occupies <10% of  the total oocyte volume, the proteins 
in the cytoplasmic lanes are derived from a larger volume than 
those in the GV lanes. The concentration of newly synthesized C 
protein is, therefore, higher in the nucleus than in the cytoplasm 
for all time points. 
tures at all time periods, although at later times the B snurpo- 
somes were occasionally stronger (Fig. 4, i and j). 
The labeling of A  snurposomes, which are particularly 
rich in U1 snRNPs (Wu et al.,  1991), was inconsistent. All 
A snurposomes within a given preparation had comparable 
levels of stain, but different preparations made at the same 
time showed widely varying levels (data not shown). 
In general, C protein translated from injected transcripts 
localized  in  the  three  structures  known  to  contain  U1 
snRNAs and associated proteins,  lampbrnsh chromosome 
loops and the A and B snurposomes (Gall and Callan, 1989; 
Wu et al., 1991). The strong accumulation in C snurposomes 
was not expected and remains somewhat of a mystery, as dis- 
cussed later.  Other structures that lack U1 snRNA, such as 
the multiple nucleoli, chromomeres, axial granules, and cer- 
tain specific loops (giant loops on chromosome 2 and the so- 
called  "sequentially labeling  loops"  on  chromosome  11) 
failed to label with mAb 9El0 after CMA injection (Fig. 4, 
k and l). As shown before (Roth and Gall, 1989; Peculis and 
Gall, 1992),  mAb 9El0 stains a few small loops in control 
GVs, but this slight background does not interfere with the 
patterns seen in the injected oocytes. 
The intranuclear distribution of endogenous UI  snRNPs 
was demonstrated in control, uninjected oocytes by staining 
with human serum 361, which specifically immunoprecipi- 
tates U1 snRNPs (D. Wassarman, unpublished observation). 
Serum 361 stained chromosome loops and the three types of 
snurposomes (Fig. 5; see also Wu et al.,  1991). It consis- 
tently gave  strong  staining of A  snurposomes,  moderate 
staining of B snurposomes, and weak staining of C snurpo- 
somes. 
To  show that the  intranuclear distribution of the myc- 
snRNP C fusion protein was not due to the myc tag alone, 
two additional myc constructs, one encoding the Xenopus 
nucleolar protein NO38, and one containing a fragment of 
pyruvate kinase eDNA fused to the SV-40 nuclear localiza- 
tion signal were injected as controls. As expected from ear- 
lier experiments (Peculis and Gall,  1992),  the translation 
products of these two constructs accumulated in the GV, 
NO38  in the nucleoli and pyruvate kinase in the soluble 
nucleoplasm.  Both  patterns  were  clearly  distinguishable 
from that of the myc-snRNP C protein. 
Assembly of  myc-snRNP C Fusion Protein 
into U1 snRNPs 
To further characterize the transport and accumulation of C 
protein in the GV, we tested whether newly synthesized myc- 
snRNP C fusion protein was assembled into intact snRNPs. 
Total snRNPs were immunoprecipitated from GV extracts of 
injected and uninjected Xenopus or Notophthalmus oocytes 
and assayed for the fusion protein by immunoblotting with 
mAb 9El0. The immunoprecipitations were made with the 
anti-Sin mAb Y12 (Lerner et al., 1981). These experiments 
showed that the majority of the myc-snRNP C protein was 
coprecipitated with the total snRNPs, suggesting that a large 
fraction of it was properly assembled into intact snRNPs 
(Fig. 6).  The minor fraction of unprecipitated myc-snRNP 
C protein which remained in the supernatant in these experi- 
ments (Fig. 6, lane 5) could represent protein that had not 
been assembled into snRNPs, or could result from inefficient 
immunoprecipitation of assembled snRNPs by mAb Y12. 
The immunoprecipitation experiments and the control in- 
jections suggest that the myc tag does not significantly inter- 
fere  with the  assembly  of the  fusion protein  into  intact 
snRNPs and the normal localization of these snRNPs within 
the GV. 
Localization of the snRNP C Protein after 
Cycloheximide Treatment 
If U1  snRNPs are moving from one intranuclear compart- 
ment to another, their movement might be detected more 
easily after a pulse of newly synthesized protein than during 
continuous synthesis. Therefore, protein synthesis was in- 
hibited by transferring the oocytes to a medium containing 
cycloheximide  at various times after CMA injection. Subse- 
quently, the distribution of newly synthesized myc-snRNP C 
fusion protein was monitored by immunoblotting and im- 
munofluorescence. In this experiment, the same distribution 
of the fusion protein was observed  in control and cyclo- 
heximide-treated oocytes. The intensity of stain, however, 
was markedly reduced in the cycloheximide-treated  oocytes, 
as was the amount of fusion protein detectable on immuno- 
blots (data not shown). The cycloheximide experiment sug- 
gests that there is little or no transport of the myc-snRNP C 
fusion protein from one intranuclear organelle to another 
during the time course of this experiment. 
Nuclear Transport of the snRNP C Protein 
The import of most srLRNPs into the nucleus, including U1, 
is dependent on preassembly of proteins and snRNA in the 
cytoplasm, with several proteins unable to enter the nucleus 
on their own (Andersen and Zieve, 1991). Pulse label and 
fractionation experiments  of tissue  culture  cells  suggest, 
however,  that the C protein can enter the nucleus indepen- 
dently in somatic cells (Feeney et al.,  1989).  To study the 
nuclear transport of the C protein in oocytes, we carried out 
experiments in which the endogenous U1 snRNA was trun- 
cated at  its  5' end by injection of the antisense oligode- 
oxynucleotide (oligo)  Ula  (Pan  and Prives,  1988, 1989). 
2-12 h  later,  CMA  was  injected,  and the localization of 
The Journal  of Cell Biology,  Volume 119, 1992  1040 Figure 4. Distribution of the snRNP C protein. Spread GV contents from Notophthalmus oocytes prepared at 9 (a and b),  18 (c and d), 
36 (e and f) and 60 (8 and h) h after injection of CMA. (a, c, e, and g) Differential interference contrast (DIC) and (b, d, f, and h) im- 
munofluorescence images in the fluorescein channel of the same region stained with mAb 9El0 to show the distribution of the myc-snRNP 
C  fusion protein.  (a and b) At 9 h after injection only weak labeling of C  snurposomes (C) is seen. (c and d)  18 h  after injection, B 
snurposomes (B) and lampbrush chromosome loops show first signs of labeling, which subsequently increases (e and f) until maximal 
labeling is reached 60 h after injection (g and h). The multiple nucleoli remain unlabeled throughout.  DIC (i) and immunofluorescent 
(]) images of a C snurposome with two attached B snarposomes (arrows) 40 h after injection of CMA.  The two B snurposomes show 
maximal labeling, whereas the C snurposome has already decreased somewhat in intensity.  Phase contrast (k) and immunofluorescent (1) 
images of the giant loops (GL) found on chromosome 2. These loops do not accumulate the C protein (they also fail to label with anti-snRNP 
antibodies and in situ hybridization probes against U  snRNAs). N, nucleolus. Bar,  10/~m. 
Jantsch and Gall Ul-specific Small Nuclear  Ribonucleopro~ein C Protein  1041 Figure 5. DIC (a) and immunofluorescent (b) images of lampbrnsh chromosome loops of Notophthalmus stained with serum 361, which 
is specific for I21 snRNPs. DIC (c) and immunofluorescent (d) images of  lampbrush loops from a CMA injected oocyte stained with mAb 
9El0. The distribution of endogenous U1 snRNPs (a and b) and exogenous snRNP C protein (c and d) is essentially identical. B and C, 
B and C snurposomes, respectively; N, nucleolus. Bar, 10 #m. 
newly synthesized myc-snRNP C  fusion protein was moni- 
tored  by  immunoblotting  and  immunofluorescence.  The 
cleavage  of  U1  snRNA  was  simultaneously  followed  by 
Northern blots. It has been shown previously that U1 snRNA 
truncated at the 5' end cannot enter the nucleus, because the 
trimethylguanosine cap is  required for nuclear migration 
(Hamm et al.,  1990). 
As expected from earlier studies (Pan and Prives,  1988, 
1989; Tsvetkov et al.,  1992), the injection of the Ula oligo 
caused rapid  cleavage of U1  snRNA,  with  no detectable 
resynthesis for up to 65 h (Fig. 7). During this time, immu- 
noblots showed that the nuclear accumulation of the CMA 
translation product proceeded as in control oocytes that had 
Figure 6. Incorporation of the 
myc-snRNP C protein into in- 
tact  mRNPs.  Proteins  from 
50 Xenopus GVs from CMA 
injected (CMA +) and unin- 
jected (CMA -) oocytes were 
immunoprecipitated  with mAb 
Y12  attached  to  protein  A 
beads (lanes 1, 2, 4, and 5), or 
with  protein  A  beads  alone 
(lanes 3 and 6). The precipi- 
tates (IP) and corresponding 
supernates (SN) were subse- 
quently  probed with mAb 9ElO, 
which detects the myc tag. The precipitate from CMA-injected oo- 
cytes is positive (lane 2), and there is a weaker signal in the corre- 
sponding supernate (lane 5). The precipitate and supernate from 
uninjected oocytes show no signal (lanes 1 and 4). Protein A beads 
alone failed to bring down myc-tagged  proteins from CMA-injected 
oocytes (lane 3), leaving the entire signal in the corresponding su- 
pernate (lane 6). The arrowhead marks the position of the myc- 
snRNP C fusion protein. Asterisks indicate IgG heavy and light 
chains of mAb Y12, visualized by the enzymatic detection system 
used for this immunoblot. Comparable results were obtained when 
the experiment was performed on Notophthalmus oocytes. 
not received the Ula oligo (data not shown). The intranuclear 
distribution of the myc-snRNP C protein was similar in con- 
trol and oligo-injected oocytes (Fig. 8). The only difference 
observed by immunofluorescence was less intense labeling 
of chromosome loops in oocytes injected with the oligo. 
Because the myc-snRNP C fusion protein presumably en- 
tered  the  GV  as  free  protein,  yet  showed  the  same  in- 
tranuclear localization as in controls, we wanted to know 
whether it was associated with the truncated, inactive U1 
snRNA. We immunoprecipitated U1 snRNPs from newt or 
Xenopus  oocytes  injected  with  CMA,  using  rnAb  9El0 
directed against the myc tag. Some oocytes had been prein- 
jected with the Ula oligo to truncate the U1 snRNA. The im- 
munoprecipitated material was then tested for full-length vs. 
truncated U1 snRNA by Northern blots (Fig. 9). As a con- 
trol,  all  splicing  snRNPs  were immunoprecipitated from 
comparable oocytes using mAb Y12. In these experiments 
both truncated (AU1) and full-length U1 snRNAs were im- 
munoprecipitated by rnAb 9El0 (Fig. 9, lanes 2 and 3 respec- 
tively), demonstrating that the myc-snRNP C fusion protein 
was associated in the GV with truncated U1  snRNA.  The 
control immunoprecipitations with mAb Y12 showed that U1 
Figure  7.  Northern  blot  of 
snRNAs from single GVs of 
Notophthalmus isolated from 
control oocytes, or oocytes in- 
jected 15 or 65 h previously 
with the  antisense Ula oligo 
(crU/a). The blot was probed 
simultaneously for UI and U6 
snRNAs. The oligo injection 
converts U1 snRNA to a trun- 
cated form (A  U/), which is 
stable  within the  GV for at 
least 65 h. U6 is unaffected  by 
injection of the Ula oligo. 
The Journal of Cell Biology,  Volume 119, 1992  1042 Figure 8. Comparison of myc-snRNP C protein in GVs from oocytes that had been injected with the Ula oligo and 24 h later with CMA 
RNA (a and b), or with CMA RNA only (c and d). Corresponding DIC and immunofluorescent images are shown of preparations stained 
with mAb 9El0. In both cases C snurposomes (C) and the B snurposomes (B) on their surface are well labeled. After Ola oligo injection 
(b) the loops are positive, but less well labeled than in the absence of the oligo (d). Nucleoli  (N) are unlabeled.  Bar, 10 #m. 
snRNPs with truncated U1 snRNA contained the usual com- 
plement of Sm proteins B  and D  (Fig.  9,  lanes 4  and 5). 
To determine whether the myc-snRNP C  fusion protein 
had interacted nonspecifically with other splicing snRNPs in 
the GV, the Northern blots were rehybridized with probes for 
the other splicing snRNAs (Fig. 9). Whereas mAb Y12 im- 
munoprecipitated U1-U6 snRNAs,  including  the truncated 
U1,  mAb 9El0  precipitated only the  full-length and trun- 
cated forms of U1, suggesting that the myc-snRNP C fusion 
protein interacted only with the U1  snRNP in the GV. 
Localization of the snRNP C Protein in Somatic Cells 
It has been known for some time that snRNP components are 
distributed in a speckled pattern in interphase nuclei (Lerner 
et al.,  1981;  Spector,  1984,  1990).  Depending on the cell 
type, the fixation protocol, and the antibody probe, the im- 
munofluorescence pattern can be somewhat variable, rang- 
ing from numerous discrete areas of stain with a low back- 
ground to a  relatively diffuse staining of the nucleus with 
only a few stronger patches (Fu and Maniatis, 1990; Carmo- 
Fonseca et al.,  1991a,b; Carter et al.,  1991; Spector et al., 
1991).  The relationship of the nuclear speckles observed in 
somatic cells to the A, B, and C snurposomes of the amphib- 
ian GV is not known. 
To study the intranuclear localization of the myc-snRNP 
C fusion protein in somatic cells, we transfected HeLa cells 
with a  plasmid expressing the entire CMA coding region. 
The cells were grown on coverslips,  fixed with formalde- 
hyde,  and  stained  simultaneously with mAb 9E10,  which 
stains only the fusion protein, and with serum 361,  which 
reveals all U1  snRNPs.  As expected, transfected as well as 
nontransfected nuclei were stained in a punctate pattern by 
serum 361  (Fig.  10 c).  In the transfected ceils, mAb 9E10 
stained in a  similar pattern (Fig.  10 b).  Serum 361  stains 
both the fusion protein and endogenous Ul-specific proteins. 
Thus, in the transfected cells, regions stained by mAb 9E10 
must also be stained by 361, although the converse would not 
necessarily be true.  In fact, within a  given transfected nu- 
cleus,  the two stains were colocalized (Fig.  10,  b  and c), 
demonstrating that new snRNP C protein is found wherever 
there are U1 snRNPs. Nucleoli were unstained in all cases. 
Figure  9.  Xenopus oocytes 
were  injected  with  the  Ula 
oligo (crU/a +), RNA encod- 
ing the myc-snRNP C protein 
(CMA  +),  or  the  oligo 
and  subsequently  the  RNA. 
snRNPs  from  hand-isolated 
GVs  were  immunoprecipi- 
tated  with  mAb 9El0  (lanes 
1-3), mAb Y12 (lanes 4 and 
5),  or no antibody  (lane  6), 
the  snRNAs  extracted  with 
phenol/chloroform,  and elec- 
trophoresed  on a  10%  acryl- 
amide/8 M urea gel. The RNAs were transferred to a GeneScreen 
filter, and probed for U1,  U2,  U4,  and U6 snRNAs,  mAb 9El0 
reacts with the myc tag in the myc-snRNP C fusion protein. Because 
mAb 9El0 precipitates both truncated  (lane 2) and full-length UI 
snRNA (lane 3), we conclude that the fusion protein can interact 
in the GV with the tnmcated RNA, presumably by exchange into 
previously  assembled  U1  snRNPs,  mAb Y12 recognizes the Sm 
epitope  and precipitates  all major snRNAs (lane 5, but data not 
shown for U5 snRNA). Because it also precipitates  the truncated 
version of UI snRNA in injected oocytes (lane 4), Sm proteins are 
presumably  associated with the truncated  RNA.  The presence of 
fuU-length U1 in lane 4 is probably due to poor injection of  the oligo 
into one of  the oocytes in this sample. Because mAb 9E10 immuno- 
precipitates poorly, extracts from 30 GVs were used with this anti- 
body compared with five GVs with mAb Y12. In addition, the anto- 
radiographic exposure for lanes 1-3 was twice that for lanes 4-6. 
Comparable results were obtained  when the experiment was per- 
formed on Notophthalmus oocytes. 
.Iantsch and Gall Ul-specific Small Nuclear Ribonucleoprotein C Protein  1043 Figure 10. Distribution of endogenous U1 snRNPs and transiently expressed snRNP C protein in the same nuclei, 24 h after transfection. 
HeLa cells were fixed in paraformaldehyde and Triton X-100 following the protocol in Fu and Maniatis (1990). Phase contrast (a) and 
immunofluorescent (b and c) images of the same nuclei. (b) Nuclei from two transfected cells showing the distribution of transiently ex- 
pressed myc-snRNP C fusion protein, detected with mAb 9El0 followed  by a fluorescein-labeled secondary antibody (not all cells express 
the protein). (c) The same field showing the distribution of endogenous U1 snRNPs in the lower nucleus and endogenous +  exogenous 
snRNP C protein in the upper two nuclei. Detected with human serum 361, which stains all U1 snRNPs, followed  by a rhodamine-labeled 
secondary antibody. Note the colocalization of label in panels b and c, which were taken with the Zeiss confocal laser scanning microscope. 
Bar,  10 #m. 
Discussion 
The Ul-specific snRNP C Protein 
Cell  fractionation  and  immunoprecipitation  experiments 
have shown that the C protein is a specific constituent of U1 
snRNPs  (Lelay-Taha et  al.,  1986;  Bringmann  and  Ltihr- 
mann,  1986). The Xenopus cDNA isolated by us encodes a 
protein with 92 % sequence identity to the human C protein 
(Sillekens et al.,  1988). Both the Xenopus and human pro- 
teins contain a cys-cys/his-his motif at the amino terminus 
that could form a zinc finger (Berg, 1988). In vitro assembly 
experiments have shown that the putative zinc finger region 
is  important  for the binding of the human protein to  U1 
snRNPs (Nelissen et al.,  1991).  Consistent with the func- 
tional significance of this region, the Xenopus and human se- 
quences are identical for the first 67 amino acids, including 
all of the putative zinc finger region. We found that myc-C 
fusion proteins with either one or 6 myc tags at the amino 
terminus  accumulated  in  the  GV,  but did  not localize in 
structures known to contain U1 snRNPs.  The myc tag may 
have affected the formation or stability of the zinc finger it- 
self, or it may have interfered sterically with binding of this 
region to an attachment site on the U1 snRNE By contrast, 
myc-C fusion proteins with the tag at the carboxy terminus 
accumulated in the GV and localized on specific intranuclear 
structures. 
Localization and Assembly of the C Protein 
Within the GV the myc-tagged C protein was detectable by 
immunofluorescence in the lampbrush chromosome loops 
and  in  the  snurposomes,  structures  known  from  earlier 
studies to contain U1 snRNPs (Wu et al., 1991). Conversely, 
immunofluorescent staining was not seen in structures that 
lack U1 snRNPs, such as the nucleoli, chromomeres, axial 
granules, and certain specific loops. When other myc-tagged 
constructs were injected into the oocyte, entirely different 
patterns of localization were observed (Roth and Gall, 1989; 
Peculis and Gall,  1992). 
Immunoprecipitations confirmed that most of the newly 
synthesized C protein was associated with intact U1 snRNPs. 
We conclude, therefore, that the myc-tagged fusion product 
behaved normally in the GV in the sense that it was incorpo- 
rated into UI snRNPs and its intranuclear distribution was 
similar to that of endogenous U1  snRNPs. 
A similar conclusion can be drawn about the behavior of 
myc-tagged C protein in transfected cells. In this case, the C 
protein localized in the nucleus in a punctate pattern identi- 
cal to that of endogenous U1  snRNPs (Fig.  10). 
Kinetics of OrganeUe Labeling 
Although it is relatively easy to follow the bulk movement 
of newly synthesized C protein from the cytoplasm into the 
GV, and to determine that it is assembled into intact snRNPs, 
it is difficult to predict the immunofluorescent staining pat- 
terns expected for individual nuclear organelles. These pat- 
terns will depend on several factors, including (a) how the 
newly synthesized protein enters the GV and whether it can 
exchange with protein in preexisting snRNPs,  (b) whether 
and how rapidly snRNPs are moving from one organelle to 
another,  (c) whether any of the organelles are essentially 
storage granules with little or no turnover, and (d) whether 
experimental overproduction of a protein disturbs the nor- 
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slowly over weeks with little morphological change except 
size, differs from that in rapidly dividing tissue culture cells, 
where one expects the distribution of old and new protein to 
be identical after one or two cell doublings. 
With these considerations in mind, one can examine the 
immunofluorescence patterns in the GV at various times af- 
ter injection of transcripts. There was a general rise in the 
intensity of fluorescence over the course of an experiment, 
consistent with the increasing amount of newly synthesized 
protein detectable in the GV by immunoblots (Figs. 3 and 4). 
Beyond this, there were changes in the relative intensity of 
different structures. In general, C snurposomes labeled first, 
followed by the chromosome loops and B snurposomes. The 
A snurposomes also labeled, but in an inconsistent manner 
from experiment to experiment. Among these structures, the 
chromosome loops and B snurposomes together account for 
the great majority of fluorescence (r~a et al.,  1991). 
If the differences in relative intensity were due to move- 
ment of U1 snRNPs between components, the effect should 
be accentuated in a pulse-label experiment. We therefore 
carded out the cycloheximide experiment, in which protein 
synthesis was shut down "-,3-8 h after injection of the tran- 
script. In this case, the overall level of fluorescent staining 
was reduced, reflecting less newly synthesized protein, but 
the pattern of labeling was similar to that in the experiments 
without cycloheximide. That is, C snurposomes labeled first, 
followed by loops and B snurposomes. 
The absence of a clear-cut progression of label from one 
structure to another, and the fact that the labeling pattern was 
essentially the same with continuous and pulse label, sug- 
gested that the newly synthesized C protein might enter all 
U1  snRNPs more or less simultaneously. In other words, 
there might be exchange of new for old C protein in intact 
151 snRNPs in the GV, as was shown to occur in vitro when 
human C  protein was  incubated with  intact  U1  snRNPs 
(Nelissen et al., 1991). To test this possibility, an antisense 
oligo that causes truncation of U1 snRNA was injected, and 
2-12  h  later transcripts  for the C  protein were  injected. 
When the GV contents were immunoprecipitated with mAb 
9El0 against the myc tag, newly synthesized C protein was 
coprecipitated with truncated U1  snRNA.  Earlier experi- 
ments with the Ula oligo (Pan and Prives, 1988, 1989; Prives 
and Foukal, 1991; Tsvetkov et al., 1992) showed that trunca- 
tion of U1 snRNA is complete within "~30 min, the oligo it- 
self degrades with a half-life of ~10 min, and there is no 
significant synthesis of new U1 snRNA during the ensuing 
1-2 d. There is presumably no pool of free U1 snRNA in the 
oocyte,  and  even  if there  were  free  U1  snRNA  in  the 
cytoplasm, it could not enter the nucleus after truncation 
(Hamm et al., 1990).  Thus we feel confident that all of the 
truncated U1 snRNA in the GV was present in preassembled 
U1 snRNPs from the beginning of the experiment. This be- 
ing the case, newly synthesized C protein must have entered 
the GV on its own, as shown earlier by Feeney et al. (1989) 
for tissue culture cells. Once inside the GV, the new C pro- 
tein exchanged with old C protein present in U1 snRNPs; or 
it entered U1 snRNPs in the GV that lacked C protein at the 
beginning of the experiment. In either case, the new C pro- 
tein would be associated with truncated UI  snRNA. This 
pathway for entry of new C protein into the GV would ex- 
plain why all structures that contain U1 snRNPs became la- 
beled more or less simultaneously and why there was little 
difference between continuous and pulse-label experiments 
except in total amount of label.  The differences between 
structures in rates of labeling could be caused by differences 
in accessibility of U1 snRNPs for exchange. 
The antisense injection experiments raise another question 
about accumulation of the C protein in the nucleus. Under 
normal circumstances the C protein is restricted to the nu- 
cleus, yet it has no obvious nuclear localization signal of the 
type described for SV-40 large T antigen, nucleoplasmin, or 
other nuclear proteins (reviewed in Dingwall and Laskey, 
1991). Because of its small size (29 kD) the C protein may 
be able to diffuse through the nuclear pores (Paine et al., 
1975). Once inside the nucleus, it may remain because of its 
association with U1 snRNPs. 
C Snurposomes 
Although most of  our observations on the intranuclear distri- 
bution of newly synthesized C protein are consistent with a 
simple exchange of new for old C protein in each of the nu- 
clear organelles, the labeling of C  snurposomes was more 
complex. C snurposomes are bipartite structures, consisting 
of a matrix and one or more inclusions of  various sizes (Cal- 
lan and Gall, 1991; Gall, 1992). In situ hybridization shows 
that splicing snRNAs are limited to the inclusions (unpub- 
lished), even though the matrix stains strongly with mAb 
Y12  against  Sm  proteins  and  mAb  K121  against  the 
trimethylguanosine cap of snRNAs (Gall and Callan, 1989; 
Wu et al., 1991). Human serum 361, which reacts with the 
C protein, stains the entire C snm'posome weakly (Wu et al., 
1991). Thus we did not expect to see much accumulation of 
C protein in the C snurposomes in the injection experiments. 
However, the C snurposomes were the first structures detect- 
able by immunoffuorescence  and they remained as bright as 
the loops and B snurposomes during the first 24-48 h. After 
that time, the C snurposomes sometimes lost label relative 
to the loops and B snurposomes. These results suggest the 
possibility that some of the C  protein that enters the GV 
passes first through the C  snurposomes. Because the myc- 
tagged C protein is clearly in the matrix of the C snurpo- 
somes, which has little or no U1 snRNA, it may occur as free 
protein in this organelle. In another study involving the in- 
tranuclear localization of  newly synthesized NO38, normally 
a  strictly nucleolar protein,  some deletion constructs ex- 
hibited strong labeling of the C snurposomes (Peculis and 
Gall, 1992). Although these observations are at present frag- 
mentary, they hint that C snurposomes may play some role 
in the distribution of proteins within the nucleus. 
A Snurposomes 
The snRNP composition of A snurposomes is simpler than 
that of B's or C's. Of the splicing components for which we 
have tested, they contain only U1 snRNA and associated pro- 
teins (Wu et al., 1991). We were, therefore, surprised by the 
inconsistent labeling of these organelles with the myc-tagged 
C protein. Our assessment of the A snurposomes was com- 
plicated by the fact that they can vary greatly in number and 
size, and can be morphologically indistinguishable from B 
snurposomes (Wu et al.,  1991). It is thus possible that we 
confused A and B snurposomes in some preparations where 
they were equally labeled. A and B snurposomes can be dis- 
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staining of/~s with human serum 361,  which specifically 
recognizes U1  snRNPs.  Unfortunately, this serum recog- 
nizes the C protein, and gave the same staining pattern as the 
anti-myc antibody in GVs  from injected oocytes.  Thus  it 
could not be used to distinguish A and B snurposomes in the 
injection experiments. We can conclude that newly synthe- 
sized C protein enters A snurposomes, but beyond this, our 
observations do not suggest a specific role for these struc- 
tures. 
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